Table 7.
Guideline Use and Utility
| PCP (n = 318) | Hepatology (n = 57) | Gastroenterology (n = 156) | Endocrinology (n = 98) | |
|---|---|---|---|---|
| Which guidelines do you use to inform or guide your management decisions for patients with suspected or diagnosed NASH? (select all that apply) | ||||
| AASLD/ACG/AGA Joint Guideline | 34% | 86% | 84% | 22% |
| EASL-EASD-EASO Clinical Practice Guidelines | 16% | 33% | 18% | 30% |
| World Gastroenterology Organization (WGO) Global Guideline | 15% | 5% | 7% | 6% |
| Coverage policies or guidelines from healthcare payors | 18% | 7% | 7% | 14% |
| Guidelines developed by my institution or practice | 30% | 5% | 6% | 16% |
| Other | 5% | 0% | 1% | 8% |
| None | 24% | 4% | 7% | 33% |
| How useful do you find clinical practice guidelines to be in managing your patients with suspected or diagnosed NASH? | ||||
| Not Applicable/have not used | 13% | 4% | 1% | 14% |
| Not at all useful | 2% | 5% | 3% | 10% |
| Slightly useful | 22% | 19% | 24% | 22% |
| Moderately useful | 33% | 40% | 40% | 29% |
| Very useful | 23% | 26% | 26% | 22% |
| Extremely useful | 6% | 5% | 6% | 2% |